IL1B and osteoarthritis: The authors of the current study would have expected similar effects after AT-MSC injection, because these cells are known to exert anti-inflammatory effects [85–87]: human AT-MSCs led to a reduced inflammatory response in synovial cells from patients with osteoarthritis by inhibition of pro-inflammatory cytokines such as IL-1β and IL-6 [85].